Related Experiment Video
Updated: Jun 29, 2026
10:38
Induction of Experimental Autoimmune Hypophysitis in SJL Mice
Published on: December 18, 2010
Solitary pituitary sarcoidosis with normal endocrine function: case report
Promod Pillai1, Abhik Ray-Chaudhury, Mario Ammirati
1Department of Neurological Surgery, The Ohio State University Medical Center, Columbus, OH 43210, USA. promod.pillai@osumc.edu
Journal of Neurosurgery
|March 4, 2008
Summary
Isolated pituitary sarcoidosis is rare, presenting challenges in diagnosis and treatment. This case highlights a unique presentation without systemic or other central nervous system involvement, emphasizing the need for biopsy confirmation.
Area of Science:
- Neurology
- Endocrinology
- Pathology
Background:
- Sarcoidosis is a multisystemic granulomatous disease affecting multiple organs.
- Neurosarcoidosis impacts the central nervous system (CNS) in 5-9% of patients, often presenting as meningeal and parenchymal lesions.
- Hypothalamic-pituitary sarcoidosis is a rare manifestation, occurring in less than 10% of neurosarcoidosis cases, and can lead to significant endocrinological dysfunction.
Observation:
- The authors report a rare case of isolated pituitary sarcoidosis.
- The patient initially presented with visual symptoms.
- Crucially, the patient exhibited no preoperative endocrinological dysfunction or evidence of systemic or other CNS sarcoidosis involvement.
Findings:
- This presentation is exceptionally rare, with only one other similar case reported in the English literature.
- Diagnosis of isolated pituitary sarcoidosis is challenging, particularly without concurrent systemic disease.
- Definitive diagnosis requires histological confirmation of noncaseating epithelioid granuloma via biopsy, alongside the exclusion of other potential conditions.
Implications:
- Isolated pituitary sarcoidosis poses diagnostic and therapeutic challenges.
- Early recognition and biopsy are critical for accurate diagnosis and management.
- This case underscores the importance of considering sarcoidosis even in the absence of typical systemic or neurological manifestations.
Related Concept Videos
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
01:17The Pituitary Gland
The pituitary is a small endocrine organ in the sphenoid bone under the hypothalamus. Primarily, the pituitary in adults has two distinct anatomical and functional regions— the anterior and posterior lobes. During human fetal development, a third pituitary gland region called the pars intermedia atrophies and disappears. However, some of its cells migrate and exist adjacent to the anterior pituitary in adults.
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:23Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
01:26Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...